about
Microarray analysis in pulmonary hypertensionNoninvasive urinary metabolomic profiling identifies diagnostic and prognostic markers in lung cancer.Improving lung cancer survival; time to move onScreening tests: a review with examplesStatus and perspectives of detection by low-dose computed tomography or computed radiography in surgical patients with lung cancer, based on a five-year study.Status and Perspectives of Clinical Modes in Surgical Patients With Lung Cancer: A Retrospective Study.Personalized medicine in screening for malignant disease: a review of methods and applications.High-speed spectral nanocytology for early cancer screening.Five-year malignancy incidence in patients with chronic pruritus: a population-based cohort study aimed at limiting unnecessary screening practicesThe contribution of risk prediction models to early detection of lung cancer.Lactate dehydrogenase and creatine kinase as poor prognostic factors in lung cancer: A retrospective observational study.Evaluation of the effect of double reporting on test accuracy in screening and diagnostic imaging studies: A review of the evidence.Astragaloside IV sensitizes non-small cell lung cancer cells to gefitinib potentially via regulation of SIRT6.Serum proteomic test in advanced non-squamous non-small cell lung cancer treated in first line with standard chemotherapy.False-positive anti-retinal antibodies as a cause of psychogenic vision loss.Short-term inpatient-based high-intensive pulmonary rehabilitation for lung cancer patients: is it feasible and effective?Lung cancer-associated pulmonary hypertension: Role of microenvironmental inflammation based on tumor cell-immune cell cross-talk.Performance of ultralow-dose CT with iterative reconstruction in lung cancer screening: limiting radiation exposure to the equivalent of conventional chest X-ray imaging.Trichostatin A reverses the chemoresistance of lung cancer with high IGFBP2 expression through enhancing autophagy.[Relationship between Clinical Characteristics and Diagnostic Modes of Hospitalized Surgical Patients with Lung Cancer].Serum Lipidomics Profiling to Identify Biomarkers for Non-Small Cell Lung Cancer
P2860
Q26748607-4EEB1579-5983-4366-91F0-32F17CAE2665Q33909660-D4E3D555-7E57-4986-B9CB-EB9DD6E9BEF4Q34509420-B836A975-10B7-4070-8287-3235EF2A834BQ35317799-4BD7AB72-8F6A-4EC2-BF87-BAE2A125B17AQ36477687-DA65850F-6588-404C-BFBF-130C0FC371F0Q36478094-366E330C-2F4C-4B0D-9091-E80600977B1DQ36641610-CAC99E7D-1180-4D65-83E4-BBCF84DB754EQ37280674-BA7EC5D6-1138-4BFD-891B-03F4E24D97AAQ37648132-ECFE9D29-AAC1-42B5-BB03-369561DB3EF0Q38133416-64FFD681-1FA7-404A-96E7-CB6B631434C8Q38648029-C4D12964-4140-4E97-85C1-420DA8917617Q38782332-731B2A0E-7F43-4923-B843-B52D01EE6C9DQ38819679-66E3E87E-B9C1-4F7A-85C3-8AA4754CB68FQ40451221-093CA04F-7675-429A-A69C-0FE4D36824FDQ44130396-0922985A-C113-4FE7-86AB-FB6521428520Q47111158-06D22E16-579E-458E-96EA-1359BD6B0242Q48297663-7EFDC331-D4F5-4207-A012-0A469F1F6B16Q51545751-FBFB8C18-B5E3-4B6A-9351-D79EBE92632EQ54966612-9525B56C-990A-4F1A-AA93-35162E4D04CFQ55504596-DC9469C7-3C2A-4DF4-BA82-90A87D312AE0Q58797016-EF369077-0AAB-4FFD-8BE8-1714839D4951
P2860
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Screening and early detection of lung cancer.
@en
type
label
Screening and early detection of lung cancer.
@en
prefLabel
Screening and early detection of lung cancer.
@en
P2093
P2860
P356
P1433
P1476
Screening and early detection of lung cancer.
@en
P2093
J Vansteenkiste
K Nackaerts
P2860
P304
P356
10.1093/ANNONC/MDS303
P478
23 Suppl 10
P577
2012-09-01T00:00:00Z